New Brunswick, NJ, United States of America

Dishaben V Patel

This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dishaben V Patel. Retrieved from https://idiyas.com/inventor/dishaben-v-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dishaben V Patel: Innovator in Therapeutic Compounds

Introduction

Dishaben V Patel is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds with antiviral properties. His work is recognized for its potential impact on medical treatments.

Latest Patents

Dishaben V Patel holds 1 patent for his invention titled "Therapeutic catechols." This invention provides compounds of formula I and salts thereof, wherein R-R have specific meanings defined in the specification. The pharmaceutical compositions comprising these compounds or salts are designed for therapeutic use, showcasing their useful antiviral properties.

Career Highlights

Dishaben V Patel is affiliated with Rutgers, The State University of New Jersey, where he continues to engage in innovative research. His work in the field of therapeutic compounds has positioned him as a valuable contributor to the scientific community.

Collaborations

Dishaben has collaborated with notable colleagues, including Edmond Joseph LaVoie and Eddy Arnold. Their combined expertise enhances the research and development of therapeutic solutions.

Conclusion

Dishaben V Patel's contributions to the field of therapeutic compounds highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future research in antiviral therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…